We are live on ! Find out more
AVEO

AVEO Pharmaceuticals, Inc.
AVEO

Delisted

AVEO was delisted on the 19th of January, 2023.

Back to rankings

110 hedge funds and large institutions have $368M invested in AVEO Pharmaceuticals, Inc. in 2022 Q4 according to their latest regulatory filings, with 65 funds opening new positions, 23 increasing their positions, 12 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,005% more call options, than puts

Call options by funds: $6.02M | Put options by funds: $194K

172% more capital invested

Capital invested by funds: $135M → $368M (+$233M)

103% more first-time investments, than exits

New positions opened: 65 | Existing positions closed: 32

92% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 12

43% more funds holding

Funds holding: 77 → 110 (+33)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
110
Holders Change
+33
Holders Change %
+42.86%
% of All Funds
1.77%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
65
Increased
23
Reduced
12
Closed
32
Calls
$6.02M
Puts
$194K
Net Calls
+$5.83M
Net Calls Change
+$2.42M

Top Buyers

Rank Fund Capital Flow
1
NAM
Nexpoint Asset Management
Texas
+$20.3M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$20M
3
Man Group
Man Group
United Kingdom
+$18M
4
AllianceBernstein
AllianceBernstein
Tennessee
+$16.9M
5
MF
Magnetar Financial
Illinois
+$15.6M

Top Sellers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
-$32.5M
2
ACM
AIGH Capital Management
Maryland
-$28.3M
3
RCMNY
Rubric Capital Management (New York)
New York
-$13.7M
4
WVP
Worth Venture Partners
New Jersey
-$7.12M
5
JGC
J. Goldman & Co
New York
-$5.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
TI
51
Trexquant Investment
Connecticut
$1.1M +$653K +47,130 +176%
BCM
52
BCK Capital Management
Connecticut
$1.02M +$942K +68,000 New
Squarepoint
53
Squarepoint
New York
$936K +$867K +62,618 New
Northern Trust
54
Northern Trust
Illinois
$930K +$163K +11,745 +23%
GCL
55
Glazer Capital LLC
New York
$928K +$859K +62,066 New
HF
56
HRT Financial
New York
$866K +$803K +57,975 New
Bank of New York Mellon
57
Bank of New York Mellon
New York
$803K +$520K +37,582 +233%
BCM
58
Bridgeway Capital Management
Texas
$792K – – –
Millennium Management
59
Millennium Management
New York
$737K -$1.41M -102,018 -67%
Mariner
60
Mariner
Kansas
$713K +$660K +47,691 New
LCM
61
Landscape Capital Management
New Jersey
$664K +$615K +44,436 New
EWM
62
Evercore Wealth Management
New York
$626K – – –
Ameriprise
63
Ameriprise
Minnesota
$608K -$1.63M -117,987 -74%
Voloridge Investment Management
64
Voloridge Investment Management
Florida
$606K +$562K +40,557 New
MOS
65
MGO One Seven
Ohio
$598K – – –
SC
66
Sagefield Capital
Texas
$598K +$554K +40,000 New
PCM
67
PenderFund Capital Management
British Columbia, Canada
$563K +$385K +27,800 New
Barclays
68
Barclays
United Kingdom
$515K +$369K +26,622 +340%
Group One Trading
69
Group One Trading
Illinois
$512K +$474K +34,258 New
State of Wisconsin Investment Board
70
State of Wisconsin Investment Board
Wisconsin
$466K +$432K +31,186 New
DC
71
Diametric Capital
Massachusetts
$447K +$414K +29,909 New
Walleye Capital
72
Walleye Capital
New York
$427K +$396K +28,589 New
California State Teachers Retirement System (CalSTRS)
73
California State Teachers Retirement System (CalSTRS)
California
$404K +$375K +27,054 New
CCM
74
Chicago Capital Management
Illinois
$374K +$346K +25,000 New
Wellington Management Group
75
Wellington Management Group
Massachusetts
$344K +$318K +22,988 New
1 2
3
4 5

AVEO Hedge Fund Activity: Q4 2022 in Review

110 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in AVEO Pharmaceuticals, Inc. (AVEO) for Q4 2022, worth a combined $368M — up 172% from $135M a quarter earlier.

Buyers outnumbered sellers: 65 funds opened new AVEO positions and 32 closed out — a net gain of 33 holders — while 23 added to existing stakes and 12 trimmed.

The largest buyer was Nexpoint Asset Management, opening a new position worth an estimated $20.3M. The largest seller was NEA Management Company, exiting entirely with an estimated $32.5M sold.

  • 110 institutional investors held AVEO Pharmaceuticals, Inc. (AVEO) as of Q4 2022, up from 77 in Q3 2022.
  • Funds reported $368M of AVEO Pharmaceuticals, Inc. stock for Q4 2022, up 172% quarter-over-quarter.
  • 65 funds opened new AVEO Pharmaceuticals, Inc. positions in Q4 2022 and 32 closed out, a net change of +33 holders.
  • The largest AVEO Pharmaceuticals, Inc. buyer in Q4 2022 was Nexpoint Asset Management, an estimated $20.3M added.
  • The largest AVEO Pharmaceuticals, Inc. seller in Q4 2022 was NEA Management Company, an estimated $32.5M sold.

Based on aggregated 13F filings for Q4 2022.